Cargando…

Study on clinical and biological characteristics of ameloblastic carcinoma

BACKGROUND: Ameloblastic carcinoma (AC) is an odontogenic malignant tumor which is closely related to benign ameloblastoma. Because of its rarity, diagnosis and treatment are difficult. In this study, we summarized and analyzed the clinical and biological characteristics of AC. RESULTS: Fifteen pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Zhixing, Li, Ye, Chen, Wantao, Zhao, Junfang, Zheng, Hongyu, Deng, Qing, Zha, Zhian, Zhu, Hao, Sun, Qiang, Su, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656674/
https://www.ncbi.nlm.nih.gov/pubmed/33176823
http://dx.doi.org/10.1186/s13023-020-01603-5
_version_ 1783608399128166400
author Niu, Zhixing
Li, Ye
Chen, Wantao
Zhao, Junfang
Zheng, Hongyu
Deng, Qing
Zha, Zhian
Zhu, Hao
Sun, Qiang
Su, Lei
author_facet Niu, Zhixing
Li, Ye
Chen, Wantao
Zhao, Junfang
Zheng, Hongyu
Deng, Qing
Zha, Zhian
Zhu, Hao
Sun, Qiang
Su, Lei
author_sort Niu, Zhixing
collection PubMed
description BACKGROUND: Ameloblastic carcinoma (AC) is an odontogenic malignant tumor which is closely related to benign ameloblastoma. Because of its rarity, diagnosis and treatment are difficult. In this study, we summarized and analyzed the clinical and biological characteristics of AC. RESULTS: Fifteen patients with AC and a median age of 53 years were identified. Among of them, five patients who were tested carried a BRAF-V600E mutation. Two patients presented with cervical lymph nodes and lung metastases. Primary AC was more invasive, and the bone destruction ability of the primary type was more radical than that of the secondary type. CONCLUSIONS: This study revealed that the BRAF-V600E mutation was related to the aggressive behavior of AC, and early radical resection is crucial. Moreover, targeted therapy may be a new direction in the future.
format Online
Article
Text
id pubmed-7656674
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76566742020-11-12 Study on clinical and biological characteristics of ameloblastic carcinoma Niu, Zhixing Li, Ye Chen, Wantao Zhao, Junfang Zheng, Hongyu Deng, Qing Zha, Zhian Zhu, Hao Sun, Qiang Su, Lei Orphanet J Rare Dis Research BACKGROUND: Ameloblastic carcinoma (AC) is an odontogenic malignant tumor which is closely related to benign ameloblastoma. Because of its rarity, diagnosis and treatment are difficult. In this study, we summarized and analyzed the clinical and biological characteristics of AC. RESULTS: Fifteen patients with AC and a median age of 53 years were identified. Among of them, five patients who were tested carried a BRAF-V600E mutation. Two patients presented with cervical lymph nodes and lung metastases. Primary AC was more invasive, and the bone destruction ability of the primary type was more radical than that of the secondary type. CONCLUSIONS: This study revealed that the BRAF-V600E mutation was related to the aggressive behavior of AC, and early radical resection is crucial. Moreover, targeted therapy may be a new direction in the future. BioMed Central 2020-11-11 /pmc/articles/PMC7656674/ /pubmed/33176823 http://dx.doi.org/10.1186/s13023-020-01603-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Niu, Zhixing
Li, Ye
Chen, Wantao
Zhao, Junfang
Zheng, Hongyu
Deng, Qing
Zha, Zhian
Zhu, Hao
Sun, Qiang
Su, Lei
Study on clinical and biological characteristics of ameloblastic carcinoma
title Study on clinical and biological characteristics of ameloblastic carcinoma
title_full Study on clinical and biological characteristics of ameloblastic carcinoma
title_fullStr Study on clinical and biological characteristics of ameloblastic carcinoma
title_full_unstemmed Study on clinical and biological characteristics of ameloblastic carcinoma
title_short Study on clinical and biological characteristics of ameloblastic carcinoma
title_sort study on clinical and biological characteristics of ameloblastic carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656674/
https://www.ncbi.nlm.nih.gov/pubmed/33176823
http://dx.doi.org/10.1186/s13023-020-01603-5
work_keys_str_mv AT niuzhixing studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT liye studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT chenwantao studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT zhaojunfang studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT zhenghongyu studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT dengqing studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT zhazhian studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT zhuhao studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT sunqiang studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma
AT sulei studyonclinicalandbiologicalcharacteristicsofameloblasticcarcinoma